Insider Cluster (2 insiders) ·Filed May 15, 2026

RPRX

Royalty Pharma plc
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $888K total
Actionable Insight • Neutral

The insider sales are negligible in size and follow a strong earnings report, suggesting no negative read-through. Monitor for any larger insider sales in the coming weeks, but this cluster alone does not warrant action.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
RPRX ▲ +13.73% at T+60d
NEUTRAL call ✓ call won +13.73% · α vs SPY +8.88% · entry $52.07 → $59.22
Entry anchored
May 15, 2026
via day open
T+1d
+0.65%
call +0.65% · α +1.30%
$52.41
settled 5mo ago
T+5d
+3.44%
call +3.44% · α +1.82%
$53.86
settled 4mo ago
T+20d
+4.11%
call +4.11% · α +2.53%
$54.21
settled 4mo ago
T+60d
+13.73%
call +13.73% · α +8.88%
$59.22
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Two insiders at Royalty Pharma sold a combined $888K in open-market sales on May 14, 2026, following the company's Q1 earnings beat and raised guidance reported on May 6. The sales are small relative to the $30.7B market cap (0.003%) and likely reflect routine portfolio diversification after a strong earnings release, not a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$887.5K
Insiders
2

Key Facts

  • EVP Urist Marshall sold 13,684 shares at ~$53.06 for $726K on May 14, 2026.
  • Director Norden Gregory sold 3,045 shares at $53.00 for $161K on May 14, 2026.
  • Total insider sales of $888K represent ~0.003% of RPRX's $30.7B market cap.
  • Sales occurred 8 days after RPRX reported Q1 2026 Portfolio Receipts of $925M (+10% YoY) and raised full-year guidance.
  • No open-market purchases were reported in the cluster.

Financial Impact

Total insider sales of $888K, immaterial relative to $30.7B market cap.

insider holdings

Risk Factors

  • Insider sales could accelerate if the stock continues to appreciate post-earnings.
  • No purchases in the cluster provide no bullish signal from insiders.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (16 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-RPRX-1778877697570
18 reports for RPRX
Performance horizon
100% Hit rate 3 of 3 directional calls best @ T+60▲ +15.20%May 6, 2026
Filters
Rows
Reports for RPRX — sortable, filterable
TypeNow
Sep 4, 2026
27d ago
Press Release
BEARISH ★ 5/10
$60.59 $58.47▲ +3.50%▲ +2.38%$57.16 (+5.66%)
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$61.73 $61.80▲ +0.11%▲ +0.50%$57.16 (−7.40%)
Aug 12, 2026
7w ago
144
NEUTRAL ★ 3/10
$58.56 $60.58▲ +3.45%▲ +5.41%$57.16 (−2.39%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 6/10
$57.75 $59.22▲ +2.55%▲ +2.19%$57.16 (−1.02%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$57.77 $57.96▲ +0.33%▼ −0.60%$57.16 (−1.06%)
Jul 2, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$57.77 $57.96▲ +0.33%▼ −0.60%$57.16 (−1.06%)
May 28, 2026
18w ago
Insider Cluster
NEUTRAL ★ 4/10
$55.76 $55.87▲ +0.20%▲ +2.72%$57.16 (+2.51%)
May 28, 2026
18w ago
8-K
NEUTRAL ★ 4/10
$55.76 $54.97▼ −1.42%▼ −1.12%$57.16 (+2.51%)
May 22, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$54.50 $55.18▲ +1.25%▼ −0.41%$57.16 (+4.88%)
May 15, 2026
20w ago
Insider Cluster
NEUTRAL ★ 3/10
$52.07 $53.86▲ +3.44%▲ +1.82%$57.16 (+9.78%)
Showing 10 of 18

US Market Status

Market Closed — Opens Mon (64h 15m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published May 15, 2026